FIELD: chemical-pharmaceutical industry. SUBSTANCE: composition has an active component, at least one an organic solvent, at least one partially fluorinated hydrocarbon as a propellent and, additionally, at least one an inorganic or an organic acid. Composition has 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane as fluorinated hydrocarbon; an organic solvent is ethyl alcohol; an inorganic acid is taken from a group including sulfuric, hydrochloric, nitric and phosphoric acid; an organic acid is taken from a group including ascorbic and citric acid; an active component is taken from a group including ipratropium bromide, oxytropium bromide, albuterol, pentaproterenol, triotropium bromide and fenoterol. EFFECT: improved stability to destruction and decomposition of an active substance. 13 cl, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR AEROSOLS WITH TWO OR MORE NUMBERS OF ACTIVE COMPONENTS | 1999 |
|
RU2218152C2 |
COMBINATION FROM ANTICHOLINERGIC AND STEROID AND ITS APPLICATION FOR TREATMENT OF DISEASES OF RESPIRATORY TRACTS BY INHALATION | 2004 |
|
RU2361586C2 |
MEDICAMENTS | 1995 |
|
RU2157188C2 |
NEW DRUG COMBINATIONS FOR TREATING RESPIRATORY DISEASES | 2006 |
|
RU2436578C2 |
INHALATION MEDICINES CONTAINING BETA-MEMETICS AND ANTICHOLINERGIC AGENT | 2004 |
|
RU2375059C2 |
AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
MEDICINAL COMPOSITION AS SOLUTION DESIGNATED FOR PREPARING AEROSOL FOR INHALATION | 1996 |
|
RU2223750C2 |
COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
AEROSOL FORMULATION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2567040C2 |
Authors
Dates
1999-02-20—Published
1993-12-06—Filed